tiprankstipranks
Advertisement
Advertisement

Kronox Lab Sciences Closes Trading Window Ahead of December 2025 Results

Story Highlights
  • Kronox Lab Sciences will close its trading window for designated persons from 1 January 2026.
  • The window reopens 48 hours after unaudited December 2025 results, reflecting SEBI-compliant insider trading controls.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Kronox Lab Sciences Closes Trading Window Ahead of December 2025 Results

Meet Samuel – Your Personal Investing Prophet

Kronox Lab Sciences Limited ( (IN:KRONOX) ) just unveiled an update.

Kronox Lab Sciences Limited has announced the closure of its trading window for dealings in the company’s equity shares by designated persons starting 1 January 2026, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s internal code of conduct. The window will remain closed until 48 hours after the board-approved announcement of the unaudited financial results for the quarter and nine months ended December 2025, underscoring the company’s adherence to regulatory norms designed to prevent insider trading and protect market integrity for investors and other stakeholders.

More about Kronox Lab Sciences Limited

Kronox Lab Sciences Limited is a listed Indian company whose equity shares trade on both the National Stock Exchange of India (NSE) and BSE. The company operates under the securities market framework governed by SEBI regulations and adheres to insider trading compliance norms applicable to publicly traded firms.

Average Trading Volume: 3,787

Technical Sentiment Signal: Sell

Current Market Cap: 5.23B INR

For an in-depth examination of KRONOX stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1